K. K. Lan

发表

Discrete sequential boundaries for clinical trials

K. K. Lan, D. DeMets, 1983 .

Interim treatment selection using the normal approximation approach in clinical trials

K. K. Lan, Z. Shun, Y. Soo, 2008, Statistics in medicine.

Stochastically curtailed tests in long–term clinical trials

K. K. Lan, R. Simon, M. Halperin, 1982 .

Proposals of statistical consideration to evaluation of results for a specific region in multi‐regional trials – Asian perspective

K. K. Lan, S. Chow, C. Hsiung, 2010, Pharmaceutical statistics.

On errors-in-variables for binary regression models

Raymond J. Carroll, Clifford H. Spiegelman, R. Carroll, 1984 .

Two-stage winner designs for non-inferiority trials with pre-specified non-inferiority margin

K. K. Lan, W. Shih, Shou-En Lu, 2017 .

Rank Tests Based on Censored Data and Their Sequential Analogues

Tze Leung Lai, T. Lai, K. K. Lan, 1991 .

Rank tests for survival analysis: a comparison by analogy with games.

K K Lan, K. K. Lan, J. Wittes, 1985, Biometrics.

Sequential monitoring of survival data with the Wilcoxon statistic.

J M Lachin, W F Rosenberger, K K Lan, 1995, Biometrics.

Alpha‐Spending Function

K. K. Lan, D. DeMets, 2014 .

Lan-DeMets Alpha-Spending Function

K. K. Lan, D. DeMets, 2014 .

Assessing Benefit and Consistency of Treatment Effect Under a Discrete Random Effects Model in Multiregional Clinical Trials

K. K. Lan, C. Hsiao, Hsiao-Hui Tsou, 2016 .

Designing Multiregional Trials Under the Discrete Random Effects Model

K. K. Lan, J. Pinheiro, Fei Chen, 2014, Journal of biopharmaceutical statistics.

Further Comments on the Alpha-Spending Function

K. K. Lan, D. DeMets, K. K. Gordon Lan, 2009 .

A Short Note on Sample Size Estimation

K. K. Lan, Z. Shun, 2009 .

A two sample ordered alternative test for means and variances

K. K. Lan, M. Halperin, 1987 .

The B-value: a tool for monitoring data.

K K Lan, K. K. Lan, J. Wittes, 1988, Biometrics.

Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes

Joseph C Cappelleri, Mingxiu Hu, K K Gordon Lan, 2007, Clinical trials.

APPLYING THE LAW OF ITERATED LOGARITHM TO CUMULATIVE META-ANALYSIS OF A CONTINUOUS ENDPOINT

Joseph C. Cappelleri, Mingxiu Hu, K. K. Lan, 2003 .

Interim analysis: the alpha spending function approach.

D L DeMets, K K Lan, K. K. Lan, 1994, Statistics in medicine.

Conditional Bias of Point Estimates Following a Group Sequential Test

K. K. Lan, D. DeMets, Xiaoyin F Fan, 2004, Journal of biopharmaceutical statistics.

A note on the gehan-wilcoxon statistic

K. K. Lan, W. Lou, 1998 .

Data monitoring in complex clinical trials: which treatment is better'?

Janet Wittes, K. K. Lan, J. Wittes, 1994 .

Linear rank tests for survival data : equivalence of two formulations

K. K. Lan, J. Wittes, 1990 .

Statistical aspects of early termination in the beta-blocker heart attack trial

David L. DeMets, Lawrence M. Friedman, K. K. Lan, 1984 .

An aid to data monitoring in long-term clinical trials.

D L DeMets, K K Lan, J. Ware, 1982, Controlled clinical trials.

Monitoring mortality at interim analyses while testing a composite endpoint at the final analysis.

Y H Joshua Chen, K K Gordon Lan, David L DeMets, 2003, Controlled clinical trials.

Monitoring boundaries for adverse effects in long-term clinical trials.

K K Lan, K. K. Lan, L. Friedman, 1986, Controlled clinical trials.

Statistical aspects of early termination in the beta-blocker heart attack trial.

D L DeMets, K K Lan, K. K. Lan, 1982, Controlled clinical trials.

Computations for group sequential boundaries using the Lan-DeMets spending function method.

D L DeMets, K K Lan, D M Reboussin, 2000, Controlled clinical trials.

Implementation of group sequential logrank tests in a maximum duration trial.

J M Lachin, K K Lan, K. K. Lan, 1990, Biometrics.

Changing frequency of interim analysis in sequential monitoring.

D L DeMets, K K Lan, K. K. Lan, 1989, Biometrics.

More flexible sequential and non-sequential designs in long-term clinical trial

Max Halperin, K. K. Lan, M. Halperin, 1984 .

SAMPLE SIZE RE-ESTIMATION FOR BINARY DATA VIA CONDITIONAL POWER

K. K. Lan, C. Wang, D. Keller, 2002 .

FLEXIBLE INTERIM ANALYSIS METHOD FOR SAMPLE SIZE RE-ESTIMATION AND EARLY STOPPING: A CONDITIONAL POWER APPROACH

K. K. Lan, Cynthia O. Siu, G. Lan, 2001 .

A Conditional Power Approach to the Evaluation of Predictive Power

Michael A. Proschan, Peter H. Hu, K. K. Lan, 2009 .

A Group Sequential Procedure for Interim Treatment Selection

S. Peter Ouyang, K. K. Lan, Gang Li, 2011 .

A comparison of sample size methods for the logrank statistic.

K K Lan, K. K. Lan, E. Lakatos, 1992, Statistics in medicine.

Over‐ruling a group sequential boundary—a stopping rule versus a guideline

K K Gordon Lan, John M Lachin, Oliver Bautista, 2003, Statistics in medicine.

Combined Estimation of Treatment Effects Under a Discrete Random Effects Model

K. K. Lan, José Pinheiro, 2012, Statistics in Biosciences.

Group sequential procedures: calendar versus information time.

D L Demets, K. K. Lan, D. DeMets, 1989, Statistics in medicine.

Use of spending functions for occasional or continuous monitoring of data in clinical trials.

J M Lachin, W F Rosenberger, K K Lan, 1993, Statistics in medicine.

Some implications of an alternative definition of the multiple comparison problem

K. K. Lan, M. Halperin, M. I. Hamdy, 1988 .

On the last time and the number of boundary crossings related to the strong law of large numbers and the law of the iterated logarithm

K. K. Lan, Tze Leung Lai, 1976 .

Information and information fractions for design and sequential monitoring of clinical trials

David M. Reboussin, David L. DeMets, K. K. Lan, 1994 .